Prevalence and Severity of Pruritus and Quality of Life in Patients With Cutaneous T-Cell Lymphoma

被引:70
|
作者
Wright, Abigail [1 ]
Wijeratne, Aruni [1 ]
Hung, Tracy [1 ]
Gao, Wei [2 ]
Whittaker, Sean [1 ,2 ]
Morris, Steven [1 ]
Scarisbrick, Julia [1 ]
Beynon, Teresa [1 ]
机构
[1] St Thomas Hosp, London SE1 7EH, England
[2] Kings Coll London, Kings Hlth Partners, London WC2R 2LS, England
关键词
Pruritus; itch; cutaneous T-cell lymphoma; CTCL; Skindex-29; quality of life; palliative care; MYCOSIS-FUNGOIDES; INTERNATIONAL-SOCIETY; PROGNOSTIC-FACTORS; SEZARY-SYNDROME; ORGANIZATION; SURVIVAL; PROPOSAL; OUTCOMES;
D O I
10.1016/j.jpainsymman.2012.01.012
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Context. Cutaneous T-cell lymphoma (CTCL), although rare, is associated with a significant symptom burden. Pruritus appears to be one of the most prominent and disturbing symptoms. Objectives. To describe the prevalence and severity of pruritus and quality of life (QOL) in patients with CTCL. Methods. Patients with CTCL able to complete two questionnaires were invited to complete a visual analogue scale for itch (VAS(itch)) and the Skindex-29. Prevalence of pruritus, mean score, and SD were estimated for the VAS(itch) and Skindex-29, and the Pearson's correlation coefficient was calculated to evaluate the relationship between severity of pruritus and QOL. Results. One hundred patients were recruited (mean [SD] age 57.9 [12.9] years, range 30-86 years). Eighty-eight percent reported pruritus in the preceding four weeks, 46% indicating that it was often or always a problem. The mean (SD) of VAS(itch) (n = 92) was 3.2 (3.2), range zero to 10. The mean (SD) total Skindex-29 score was 43.3 (27.7). More advanced disease stage was associated with poorer QOL. The Skindex-29 correlated strongly with the VAS(itch) (Pearson's correlation coefficient = 0.72, P < 0.001). Conclusion. All aspects of QOL are affected in CTCL. Pruritus is a common and troublesome symptom. A more advanced disease stage and more severe pruritus symptoms were associated with poorer QOL in this study. J Pain Symptom Manage 2013;45:114-119. (C) 2013 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:114 / 119
页数:6
相关论文
共 50 条
  • [21] Inflammatory cytokines and peripheral mediators in the pathophysiology of pruritus in cutaneous T-cell lymphoma
    Lewis, D. J.
    Huang, S.
    Duvic, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (10) : 1652 - 1656
  • [22] What's New in Cutaneous T-Cell Lymphoma-Associated Pruritus
    Soares, Georgia Biazus
    Guitart, Joan
    Yosipovitch, Gil
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2024, 25 (01) : 67 - 77
  • [23] Quality-of-life improvements in cutaneous T-cell lymphoma patients treated with denileukin diftitox (ONTAK®)
    Duvic, M
    Kuzel, T
    Olsen, EA
    Martin, AG
    Foss, FM
    Kim, YH
    Heald, PW
    Bacha, P
    Nichols, J
    Liepa, A
    CLINICAL LYMPHOMA, 2002, 2 (04): : 222 - 228
  • [24] A cross-sectional analysis of quality of life in skin of color patients with cutaneous T-cell lymphoma: An exploratory study
    Abraham, Jaclyn
    Wei, Grace
    Desai, Seemal R.
    Seminario-Vidal, Lucia
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (05) : 1110 - 1112
  • [25] Measurement of Quality of Life in Patients with Mycosis Fungoides/Sezary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument
    McCaffrey, Stacey
    Black, Ryan A.
    Nagao, Mitchell
    Sepassi, Marjan
    Sharma, Gaurav
    Thornton, Susan
    Kim, Youn H.
    Braverman, Julia
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2019, 21 (01)
  • [26] The role of illness perception in patients with cutaneous T-cell lymphoma
    Eseonu, Amarachi
    Burns, Austin
    Rozati, Sima
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S31 - S31
  • [27] Quality of Life in Patients With Cutaneous T-Cell Lymphoma: Validation of a Novel Quality of Life Instrument
    Akkad, Neha
    Musiek, Amy
    Jeffe, Donna
    Frank, Anastasia
    Mehta-Shah, Neha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S469 - S469
  • [28] Overall and Cause-Specific Mortality Among Patients With Cutaneous T-Cell Lymphoma in the United States
    Shea, Lauren
    Narkhede, Mayur
    Chamarti, Karthik
    Gao, Tina
    Mehta, Amitkumar
    Goyal, Gaurav
    EJHAEM, 2025, 6 (02):
  • [29] Cutaneous T-cell Lymphoma
    Lansigan, Frederick
    Choi, Jaehyuk
    Foss, Francine M.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2008, 22 (05) : 979 - +
  • [30] Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?
    Virmani, Pooja
    Hwang, Susan H.
    Hastings, Justin G.
    Haverkos, Bradley M.
    Kohnken, Becca
    Gru, Alejandro A.
    Mishra, Anjali
    Fabbro, Stephanie K.
    Horwitz, Steve M.
    Porcu, Pierluigi
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (02) : 111 - 121